このアイテムのアクセス数: 82
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
j.gore.2022.101115.pdf | 3.87 MB | Adobe PDF | 見る/開く |
タイトル: | Nivolumab for malignant transformation of ovarian mature cystic teratoma |
著者: | Yoshimura, Kayoko Yamanoi, Koji ![]() ![]() ![]() Kanai, Masashi ![]() Okunomiya, Asuka ![]() ![]() Sagae, Yusuke Sunada, Masumi ![]() ![]() Taki, Mana ![]() ![]() ![]() Ukita, Masayo Chigusa, Yoshitsugu ![]() ![]() ![]() Horie, Akihito ![]() Yamaguchi, Ken Hamanishi, Junzo ![]() ![]() Minamiguchi, Sachiko ![]() ![]() Yamamoto, Noboru Muto, Manabu ![]() ![]() ![]() Mandai, Masaki |
著者名の別形: | 吉村, 佳与子 山ノ井, 康二 金井, 雅史 奥宮, 明日香 寒河江, 悠介 砂田, 真澄 滝, 真奈 浮田, 真沙世 千草, 義継 堀江, 昭史 山口, 建 濵西, 潤三 南口, 早智子 武藤, 学 万代, 昌紀 |
キーワード: | Malignant transformation of mature cystic teratoma Immune checkpoint inhibitor Comprehensive genomic profiling test PD-L1 Tumor mutation burden |
発行日: | Dec-2022 |
出版者: | Elsevier BV |
誌名: | Gynecologic Oncology Reports |
巻: | 44 |
論文番号: | 101115 |
抄録: | Mature cystic teratoma of the ovary (MCT) occasionally undergoes malignant transformation (MT) that is resistant to chemotherapy and has a poor prognosis. We experienced a case of clinically aggressive MCT-MT that invades surrounding organs and tissues. Although tumor was resected entirely, a rapid tumor recurrence occurred during postoperative chemotherapy (paclitaxel + ifosfamide + cisplatin). The results of comprehensive genomic profiling test performed early in the postoperative period showed a high tumor mutational burden of 23 mutations/Mb. Treatment with nivolumab monotherapy has promptly been initiated and has been very successful for more than one year. |
著作権等: | © 2022 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license. |
URI: | http://hdl.handle.net/2433/284687 |
DOI(出版社版): | 10.1016/j.gore.2022.101115 |
PubMed ID: | 36560959 |
出現コレクション: | 学術雑誌掲載論文等 |

このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス